<DOC>
	<DOCNO>NCT02225340</DOCNO>
	<brief_summary>Familial hypercholesterolemia ( FH ) autosomal codominant single gene disorder cause mutation LDL receptor gene ( LDLR ) disrupt normal clearance LDL particles plasma . Heterozygous patient ( HeFH ) present two- three-fold raise plasma LDL-cholesterol ( LDL-C ) concentration coronary artery disease occur early among HeFH carry negative-receptor ( NR ) mutation compare HeFH subject carry defective-receptor ( DR ) variant . Proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) regulate LDL-C level bind LDLR enhance intracellular degradation . The objective study examine extent variation LDL-C Lipoprotein ( Lp ) ( ) concentration relate PCSK9 level large French-Canadian cohort HeFH subject . The primary hypothesis PCSK9 level significant impact LDL-C concentration variability associate Lp ( ) level .</brief_summary>
	<brief_title>Relationships Between Plasma PCSK9 Levels , LDL-cholesterol Concentrations Lipoprotein ( ) Levels Familial Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<criteria>Subjects familial hypercholesterolemia : Aged 1865 year Carrier mutation LDL receptor gene Controls : Aged 1860 year HDLcholesterol &gt; 1.1 mmol/L Triglycerides &lt; 1.7 mmol/L Fasting blood glucose &lt; 6.1 mmol/L Normal blood pressure ( &lt; 130/85 ) Subjects previous history cardiovascular disease Subjects Type 2 diabetes Were pregnant nursing ; Subjects history cancer Subjects acute liver disease , hepatic dysfunction , persistent elevation serum transaminase Subjects secondary hyperlipidemia due cause History alcohol drug abuse within past 2 year hormonal treatment Subjects situation condition , opinion investigator , may interfere optimal participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>